Growing community of inventors

Seattle, WA, United States of America

Sandy Alexander Simon

Average Co-Inventor Count = 5.76

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 32

Sandy Alexander SimonWilliam Brady (4 patents)Sandy Alexander SimonJeffrey A Ledbetter (3 patents)Sandy Alexander SimonMartha Susan Hayden-Ledbetter (3 patents)Sandy Alexander SimonPeter Armstrong Thompson (3 patents)Sandy Alexander SimonPhilip Tan (2 patents)Sandy Alexander SimonLaura Sue Grosmaire (2 patents)Sandy Alexander SimonCecile Morales (2 patents)Sandy Alexander SimonCharles G Cerveny (1 patent)Sandy Alexander SimonChristy Anne Nilsson (1 patent)Sandy Alexander SimonCharles G Cerveny (0 patent)Sandy Alexander SimonChristy Anne Nilsson (0 patent)Sandy Alexander SimonCecile Morales (0 patent)Sandy Alexander SimonSandy Alexander Simon (4 patents)William BradyWilliam Brady (28 patents)Jeffrey A LedbetterJeffrey A Ledbetter (81 patents)Martha Susan Hayden-LedbetterMartha Susan Hayden-Ledbetter (31 patents)Peter Armstrong ThompsonPeter Armstrong Thompson (9 patents)Philip TanPhilip Tan (8 patents)Laura Sue GrosmaireLaura Sue Grosmaire (3 patents)Cecile MoralesCecile Morales (2 patents)Charles G CervenyCharles G Cerveny (7 patents)Christy Anne NilssonChristy Anne Nilsson (1 patent)Charles G CervenyCharles G Cerveny (0 patent)Christy Anne NilssonChristy Anne Nilsson (0 patent)Cecile MoralesCecile Morales (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aptevo Research and Development LLC (2 from 12 patents)

2. Emergent Product Development Seattle,llc (2 from 11 patents)


4 patents:

1. 10307481 - CD37 immunotherapeutics and uses thereof

2. 10143748 - B-cell reduction using CD37-specific and CD20-specific binding molecules

3. 9101609 - CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof

4. 8333966 - CD37 immunotherapeutics and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…